Farmeposp. z o.o.

Other human health activities not elsewhere classified

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2023-05-23
Share capital
30 000,00 PLN
Activity description

Farmepo manages a nationwide network of 15 clinical research sites with 100 active investigators and 10 years of experience from 400 completed clinical trials. It supports pharmaceutical companies and CROs, medical facilities, physicians, and healthcare staff, coordinating projects from site identification through study delivery. Its therapeutic areas include cardiology, diabetology, neurology and psychiatry, dermatology, endocrinology, pulmonology, oncology, and metabolic diseases.

Registered address
ul. Gdańska 32/8, 85-006 Bydgoszcz, Poland
Website
farmepo.comWebsite active
Phone
Social media
Electronic delivery address
AE:PL-88034-30517-ARCBI-28

Financials

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 5.30mMedianUSD 92.65kAverageUSD 1.49m
Net profit
This companyUSD 1.60mMedianUSD 2.47kAverageUSD 172.62k
Operating costs
This companyUSD 3.36mMedianUSD 85.28kAverageUSD 1.26m
Assets
This companyUSD 731.71kMedianUSD 40.88kAverageUSD 1.12m

Bank accounts

Registered as a VAT taxpayer on 2024-11-01. Active

  • mBank
    48 1140 2004 0000 3002 8370 3256
  • mBank
    03 1140 2004 0000 3612 1925 6744
  • mBank
    03 1140 2004 0000 3902 8563 9939

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

No public aid cases recorded in the last 10 years.

Tenders

No recorded participation in tenders.

Authorized Representatives

Błażej Bujanowski — Attorney-in-fact (sole)
Michał Wiśniewski — President of the Management Board
Paweł Rudowski — Vice President of the Management Board

Manner of representation

Each member of the management board is authorised to make declarations of will on behalf of the company independently.

Ownership

OwnerSharesShare valueStake
Paweł Rudowski (39)
49$3,970.8349%
Michał Wiśniewski (43)
51$4,132.9051%

Beneficial owners

Person
Paweł Rudowski (39)
Michał Wiśniewski (43)

FAQ

Last updated: 2026-05-12